Acadia Pharmaceuticals Inc
ACAD- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001070494
In the last 90 days, Acadia Pharmaceuticals Inc insiders filed 0 open-market purchases and 2 sales; 354 institutions reported holding it in 13F filings for Q2 2026, worth $4.27B in total; no superinvestor holds it.
13F holders, Q1 2023
Institutional positions in Acadia Pharmaceuticals Inc as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 234
- +8 vs. Q4 2022
- Shares held
- 157.4M
- +1.63M (+1.0%) vs. Q4 2022
- Total value
- $2.97B
- +$495.1M (+20.0%) vs. Q4 2022
- New holders
- 35
- 76 more added
- Sold out
- 27
- 70 more reduced
2 institutions that held it in Q4 2022 haven't filed for Q1 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ACAD on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 354 | $4.27B |
| Q1 2026 | 343 | $3.67B |
| Q4 2025 | 336 | $4.44B |
| Q3 2025 | 334 | $3.58B |
| Q2 2025 | 311 | $3.66B |
| Q1 2025 | 320 | $2.87B |
| Q4 2024 | 296 | $2.99B |
| Q3 2024 | 258 | $2.41B |
| Q2 2024 | 265 | $2.62B |
| Q1 2024 | 268 | $2.99B |
| Q4 2023 | 277 | $4.99B |
| Q3 2023 | 249 | $3.25B |
| Q2 2023 | 236 | $3.81B |
| Q1 2023 | 234 | $2.97B |
| Q4 2022 | 228 | $2.48B |
| Q3 2022 | 223 | $2.49B |
| Q2 2022 | 246 | $2.13B |
| Q1 2022 | 262 | $3.56B |
| Q4 2021 | 247 | $3.46B |
| Q3 2021 | 238 | $2.41B |
| Q2 2021 | 245 | $3.61B |
| Q1 2021 | 272 | $3.76B |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding Acadia Pharmaceuticals Inc; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Bank of America Corp | 661,639 | $12.5M | 0.00% | −64,486−8.9% | Reduced |
| Man Group plc | – | $12.7M | 0.05% | – | – |
| Panagora Asset Management Inc | 728,001 | $13.7M | 0.09% | +47,396+7.0% | Added |
| Frazier Life Sciences Management, L.P. | 857,338 | $16.1M | 1.17% | 00.0% | Unchanged |
| Manufacturers Life Insurance Company, The | 872,050 | $16.4M | 0.01% | −57,227−6.2% | Reduced |
| Pictet Asset Management SA | 882,275 | $16.6M | 0.02% | +577,731+189.7% | Added |
| Rice Hall James & Associates, LLC | 887,126 | $16.7M | 0.95% | −70,562−7.4% | Reduced |
| Finepoint Capital LP | 916,353 | $17.2M | 6.59% | −260,477−22.1% | Reduced |
| Charles Schwab Investment Management Inc | 969,294 | $18.2M | 0.01% | −2,460−0.3% | Reduced |
| Goldman Sachs Group Inc | 979,738 | $18.4M | 0.00% | −10,885−1.1% | Reduced |
| Northern Trust Corp | 1,166,724 | $22.0M | 0.00% | +39,440+3.5% | Added |
| Wellington Management Group LLP | 1,180,637 | $22.2M | 0.00% | −399,273−25.3% | Reduced |
| Emerald Mutual Fund Advisers Trust | 1,207,302 | $22.7M | 1.34% | +158,552+15.1% | Added |
| Adage Capital Partners GP, L.L.C. | 1,225,000 | $23.1M | 0.05% | +1,225,000 | New |
| Jupiter Asset Management Ltd | 1,367,601 | $25.7M | 0.36% | +277,629+25.5% | Added |
| Emerald Advisers, LLC | 1,496,560 | $28.2M | 1.35% | +174,414+13.2% | Added |
| JPMorgan Chase & Co | 1,584,784 | $29.8M | 0.00% | −510,707−24.4% | Reduced |
| Fred Alger Management, LLC | 1,725,626 | $32.5M | 0.17% | +262,972+18.0% | Added |
| Millennium Management LLC | 1,752,013 | $33.0M | 0.04% | +549,684+45.7% | Added |
| Jacobs Levy Equity Management, Inc | 1,882,353 | $35.4M | 0.22% | +243,170+14.8% | Added |
| Norges Bank | 2,021,913 | $38.1M | 0.01% | +67,757+3.5% | Added |
| Geode Capital Management, LLC | 2,390,267 | $45.0M | 0.01% | +90,768+3.9% | Added |
| Palo Alto Investors LP | 2,405,793 | $45.3M | 3.75% | +29,424+1.2% | Added |
| First Trust Advisors LP | 2,714,485 | $51.1M | 0.06% | −167,876−5.8% | Reduced |
| Morgan Stanley | 3,914,704 | $73.7M | 0.01% | +1,169,966+42.6% | Added |
| Price T Rowe Associates Inc | 4,550,906 | $85.6M | 0.01% | +271,652+6.3% | Added |
| D. E. Shaw & Co., Inc. | 4,900,582 | $92.2M | 0.15% | +681,183+16.1% | Added |
| State Street Corp | 5,586,861 | $105.1M | 0.01% | −2,153,477−27.8% | Reduced |
| EcoR1 Capital, LLC | 5,991,479 | $112.8M | 3.64% | 00.0% | Unchanged |
| FMR LLC | 7,846,673 | $147.7M | 0.01% | −1,487,941−15.9% | Reduced |
| RTW Investments, LP | 8,242,864 | $155.1M | 3.23% | +4,571,926+124.5% | Added |
| BlackRock Inc. | 9,869,131 | $185.7M | 0.01% | −390,053−3.8% | Reduced |
| Vanguard Group Inc | 13,678,809 | $257.4M | 0.01% | +399,034+3.0% | Added |
| Baker Bros. Advisors LP | 41,938,486 | $789.3M | 4.29% | +15,0000.0% | Added |
| Braidwell LP | 0 | $0 | 0.00% | −1,493,121−100.0% | Sold out |
| Bain Capital Life Sciences Investors, LLC | 0 | $0 | 0.00% | −701,402−100.0% | Sold out |
| Ally Bridge Group (NY) LLC | 0 | $0 | 0.00% | −474,741−100.0% | Sold out |
| Bank of Montreal | 0 | $0 | 0.00% | −282,181−100.0% | Sold out |
| Tekla Capital Management LLC | 0 | $0 | 0.00% | −72,225−100.0% | Sold out |
| Partners Capital Investment Group, LLP | 0 | $0 | 0.00% | −38,318−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −30,721−100.0% | Sold out |
| NinePointTwo Capital | 0 | $0 | 0.00% | −16,702−100.0% | Sold out |
| DuPont Capital Management Corp | 0 | $0 | 0.00% | −13,228−100.0% | Sold out |
| Marex Group plc | 0 | $0 | 0.00% | −12,232−100.0% | Sold out |
| Running Point Capital Advisors, LLC | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Psagot Value Holdings Ltd. / (Israel) | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| State of Wyoming | 0 | $0 | 0.00% | −5,784−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −5,300−100.0% | Sold out |
| Exchange Traded Concepts, LLC | 0 | $0 | 0.00% | −5,240−100.0% | Sold out |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −2,578−100.0% | Sold out |
| Advisors Asset Management, Inc. | 0 | $0 | 0.00% | −1,892−100.0% | Sold out |
| Fifth Third Bancorp | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |
| Coppell Advisory Solutions LLC | 0 | $0 | 0.00% | −600−100.0% | Sold out |
| Coppell Advisory Solutions Corp. | 0 | $0 | 0.00% | −600−100.0% | Sold out |
| Corrado Advisors, LLC | 0 | $0 | 0.00% | −155−100.0% | Sold out |
| Accurate Wealth Management, LLC | 0 | $0 | 0.00% | −113−100.0% | Sold out |
| Baldwin Brothers Inc | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| Ronald Blue Trust, Inc. | 0 | $0 | 0.00% | −55−100.0% | Sold out |
| Versant Capital Management, Inc | 0 | $0 | 0.00% | −49−100.0% | Sold out |
| Natixis | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| Steward Financial Group LLC | 0 | $0 | 0.00% | −19−100.0% | Sold out |
| Boenning & Scattergood, Inc. | – | – | – | – | Not filed |
| Gibson Wealth Advisors LLC | – | – | – | – | Not filed |